デフォルト表紙
市場調査レポート
商品コード
1392721

吸入麻酔の世界市場レポート 2024年

Inhalation Anesthesia Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
吸入麻酔の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

吸入麻酔の市場規模は近年力強く成長しています。2023年の14億6,000万米ドルから2024年には15億6,000万米ドルへ、CAGR7.1%で拡大します。過去の期間に見られた拡大は、麻酔を必要とする外科手術の需要の増加、老年人口の増加、吸入麻酔薬の開発における進歩、外来手術センターの急増、心臓病やがんなどの慢性疾患の有病率の上昇に起因しています。

予想される慢性疾患の増加は、吸入麻酔市場の成長を促進する構えです。慢性疾患は、3カ月以上の長期にわたる持続が特徴で、診断、治療、管理のために外科的介入が必要となることが多いです。吸入麻酔は、このような外科的処置の際に患者に快適さと安全性を提供する上で非常に重要になります。2023年1月に発表された国立医学図書館の報告によると、50歳以上で1つ以上の慢性疾患を持つ人の数は99.5%増加し、米国では2020年の7,152万2,000人から2050年には1億4,266万人に達すると予測されています。その結果、慢性疾患の増加が吸入麻酔市場の成長を促進すると予測されます。

2023年の吸入麻酔市場では北米が最大地域でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。

目次

第1章 エグゼクティブサマリー

第2章 吸入麻酔市場の特徴

第3章 吸入麻酔市場の動向と戦略

第4章 吸入麻酔市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の吸入麻酔市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018~2023年
  • 市場規模と成長予測、2023~2028年、2033F

第6章 吸入麻酔市場セグメンテーション

  • 世界の吸入麻酔市場、製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • セボフルラン
  • デスフルラン
  • イソフルラン
  • 亜酸化窒素
  • 世界の吸入麻酔市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 誘導
  • メンテナンス
  • 世界の吸入麻酔市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 病院
  • 外来手術センター

第7章 吸入麻酔市場の地域および国分析

  • 世界の吸入麻酔市場、地域別、実績および予測、2018-2023、2023-2028F、2033F
  • 世界の吸入麻酔市場、国別、実績および予測、2018-2023、2023-2028F、2033F

第8章 アジア太平洋の吸入麻酔市場

  • 概要
  • 地域情報、COVID-19の影響、市場情報、背景情報、政府の取り組み、規制、規制機関、主要団体、課税額、法人税構造、投資、主要企業
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第9章 中国の吸入麻酔市場

第10章 インドの吸入麻酔市場

第11章 日本の吸入麻酔市場

第12章 オーストラリアの吸入麻酔市場

第13章 インドネシアの吸入麻酔市場

第14章 韓国の吸入麻酔市場

第15章 西欧の吸入麻酔市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第16章 英国の吸入麻酔市場

第17章 ドイツの吸入麻酔市場

第18章 フランスの吸入麻酔市場

第19章 イタリアの吸入麻酔市場

第20章 スペインの吸入麻酔市場

第21章 東欧の吸入麻酔市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第22章 ロシアの吸入麻酔市場

第23章 北米の吸入麻酔市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第24章 米国の吸入麻酔市場

第25章 カナダの吸入麻酔市場

第26章 南米の吸入麻酔市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第27章 ブラジルの吸入麻酔市場

第28章 中東の吸入麻酔市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第29章 アフリカの吸入麻酔市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第30章 吸入麻酔市場の競合情勢と企業プロファイル

  • 吸入麻酔市場の競合情勢
  • 吸入麻酔市場の企業プロファイル
    • Abbvie Inc.
    • Baxter International Inc.
    • Fresenius SE &Co. KGaA
    • Halocarbon Products Corporation
    • Hikma Pharmaceuticals PLC

第31章 世界の吸入麻酔市場の競合ベンチマーキング

第32章 世界の吸入麻酔市場の競合ダッシュボード

第33章 吸入麻酔市場における主要な合併と買収

第34章 吸入麻酔市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r10409

“Inhalation Anesthesia Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inhalation anesthesia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inhalation anesthesia? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The inhalation anesthesia market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Sevoflurane; Desflurane; Isoflurane; Nitrous Oxide
  • 2) By Application: Induction; Maintenance
  • 3) By End User: Hospitals; Ambulatory Surgical Centers
  • Companies Mentioned: Abbvie Inc.; Baxter International Inc.; Fresenius SE & Co. KGaA; Halocarbon Products Corporation; Hikma Pharmaceuticals PLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Inhalation anesthesia pertains to medications administered in operating rooms for the purpose of initiating and sustaining general anesthesia. Alongside other therapeutic effects, it induces varying degrees of drowsiness, ranging from mild to profound, ultimately achieving a state of general anesthesia. Inhalation anesthesia finds application in both the induction and maintenance phases of general anesthesia within the operating room.

Key products in the realm of inhalation anesthesia include sevoflurane, desflurane, isoflurane, and nitrous oxide. Isoflurane, specifically, is an inhaled general anesthetic employed for the initiation and upkeep of general anesthesia. Its action involves muscle relaxation and a reduction in pain sensitivity through the modification of tissue excitability. The uses of inhalation anesthesia encompass both the induction and maintenance phases, and the primary end-users are hospitals and ambulatory surgical centers.

The inhalation anesthesia market research report is one of a series of new reports from The Business Research Company that provides Inhalation anesthesia market statistics, including inhalation anesthesia industry global market size, regional shares, competitors with an inhalation anesthesia market share, detailed inhalation anesthesia market segments, market trends and opportunities, and any further data you may need to thrive in the inhalation anesthesia industry. This inhalation anesthesia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The inhalation anesthesia market size has grown strongly in recent years. It will grow from $1. 46 billion in 2023 to $1. 56 billion in 2024 at a compound annual growth rate (CAGR) of 7. 1%. The expansion observed during the historical period can be attributed to the increasing demand for surgical procedures necessitating anesthesia, a growing geriatric population, advancements in the development of inhalation anesthetics, the proliferation of ambulatory surgical centers, and a rising prevalence of chronic diseases such as heart disease and cancer.

The inhalation anesthesia market size is expected to see strong growth in the next few years. It will grow to $2. 14 billion in 2028 at a compound annual growth rate (CAGR) of 8. 2%. The anticipated growth in the forecast period can be attributed to an increasing demand for minimally invasive surgeries, a rise in global healthcare expenditure, a growing number of surgical procedures in emerging markets, the adoption of inhalation anesthesia in veterinary medicine, and an augmentation in government funds allocated for the research and development of innovative inhalation anesthetics. Prominent trends expected in the forecast period encompass technological innovations in anesthesia delivery systems, the development of inhalation anesthesia devices tailored for pediatric use, a shift towards the usage of sevoflurane and desflurane, a heightened focus on eco-friendly anesthetic agents, and the integration of monitoring technologies in anesthesia delivery.

The anticipated growth in the geriatric population is set to drive the inhalation anesthesia market during the forecast period. The increasing number of elderly individuals contributes to the expansion of the inhalation anesthesia market as this demographic is more susceptible to degenerative diseases and chronic illnesses, leading to a heightened demand for surgeries and therapeutic interventions. The rise in the geriatric population, prone to ailments like cardiovascular, neurological, respiratory, and degenerative disorders, plays a significant role in boosting market growth. Administering anesthesia through an intravenous route to geriatric patients can be inconvenient due to issues with punctured blood vessels and patient compliance. For example, as of October 2022, the World Health Organization reports a projected global population of 1. 4 billion individuals aged 60 years by 2022 compared to 1 billion in 2020. Additionally, it is estimated that by 2030, one out of every six people worldwide will be aged 60 years or older. Consequently, the increasing geriatric population is expected to drive the demand for inhalation anesthesia throughout the forecast period.

The expected increase in chronic diseases is poised to fuel the growth of the inhalation anesthesia market. Chronic diseases, characterized by long-term persistence over three months or more, often necessitate surgical interventions for diagnosis, treatment, or management. Inhalation anesthesia becomes crucial in providing comfort and safety to patients during these surgical procedures. A report from the National Library of Medicine, published in January 2023, projects a 99. 5% increase in the number of individuals aged 50 years and older with one or more chronic illnesses, reaching 142. 66 million by 2050 in the United States, up from 71. 522 million in 2020. As a result, the upsurge in chronic diseases is expected to propel the growth of the inhalation anesthesia market.

In response to industry demands and to strengthen their market positions globally, numerous companies in the inhalation anesthesia sector are developing innovative products like Sedaconda. Sedaconda, an inhaled sedation therapy delivered through the Anaesthetic Conserving Device (ACD), received approval for use in intensive care. For example, in February 2022, Sedana Medical AB, a Sweden-based med-tech and pharmaceutical company, introduced Sedaconda (isoflurane) to the German market. Sedaconda (isoflurane) is administered using the medical device known as Sedaconda ACD (Anaesthetic Conserving Device) and is the sole approved inhaled sedation therapy authorized for use in intensive care settings.

Leading companies in the inhalation anesthesia market are channeling their efforts into developing innovative products such as end-tidal (ET) control software to enhance their offerings. The End-tidal (Et) Control software, designed for administering general anesthesia through the Aisys CS2 Anesthesia Delivery System, received FDA pre-market approval (PMA) from GE Healthcare Technologies Inc., a US-based medical technology company, in April 2022. This software facilitates semi-automated anesthesia administration by enabling anesthesia providers to set and maintain end-tidal oxygen and anesthetic agent targets, improving precision in inhalation anesthesia delivery, streamlining workflows, reducing drug wastage, and contributing to cost savings and reduced greenhouse gas emissions in healthcare settings.

In January 2022, Dechra Pharmaceuticals, a UK-based specialist veterinary pharmaceuticals and related products business, acquired Isoflurane USP Inhalant Anesthetic and Sevoflurane USP Inhalant Anesthetic from Halocarbon Life Sciences for an undisclosed amount. This acquisition adds Isoflurane and Sevoflurane to Dechra's pharmaceutical companion animal portfolio, focusing on areas such as endocrinology, anesthesia, fluid therapy, dermatology, ophthalmology, pain management, joint health support, and dental care. Halocarbon Life Sciences is a US-based leader in supplying isoflurane and sevoflurane inhalation anesthetic products for human and veterinary applications.

Major companies operating in the in the inhalation anesthesia market report are Abbvie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, B. Braun Melsungen AG, Lunan Pharmaceutical Group Co. Ltd., Maruishi Pharmaceutical Co. Ltd., Mylan N. V., Piramal Enterprises Ltd., Recipharm AB, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Wockhardt Ltd., AstraZeneca PLC, C. H. Boehringer Sohn AG & Co. KG, Bristol-Myers Squibb Company, Eisai Co. Ltd., GlaxoSmithKline PLC, Johnson & Johnson Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi S. A., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, UCB S. A., Zydus Lifesciences Limited

North America was the largest region in the inhalation anesthesia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhalation anesthesia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the inhalation anesthesia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The inhalation anesthesia market consists of sales of nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Inhalation Anesthesia Market Characteristics

3. Inhalation Anesthesia Market Trends And Strategies

4. Inhalation Anesthesia Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Inhalation Anesthesia Market Size and Growth

  • 5.1. Global Inhalation Anesthesia Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Inhalation Anesthesia Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Inhalation Anesthesia Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Inhalation Anesthesia Market Segmentation

  • 6.1. Global Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Nitrous Oxide
  • 6.2. Global Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Induction
  • Maintenance
  • 6.3. Global Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers

7. Inhalation Anesthesia Market Regional And Country Analysis

  • 7.1. Global Inhalation Anesthesia Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Inhalation Anesthesia Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Inhalation Anesthesia Market

  • 8.1. Asia-Pacific Inhalation Anesthesia Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8. 4. Asia-Pacific Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Inhalation Anesthesia Market

  • 9.1. China Inhalation Anesthesia Market Overview
  • 9.2. China Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9. 4. China Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Inhalation Anesthesia Market

  • 10.1. India Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Inhalation Anesthesia Market

  • 11.1. Japan Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Inhalation Anesthesia Market

  • 12.1. Australia Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Inhalation Anesthesia Market

  • 13.1. Indonesia Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Inhalation Anesthesia Market

  • 14.1. South Korea Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Inhalation Anesthesia Market

  • 15.1. Western Europe Inhalation Anesthesia Market Overview
  • 15.2. Western Europe Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15. 4. Western Europe Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Inhalation Anesthesia Market

  • 16.1. UK Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Inhalation Anesthesia Market

  • 17.1. Germany Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Inhalation Anesthesia Market

  • 18. 5. France Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 6. France Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 7. France Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Inhalation Anesthesia Market

  • 19. 9. Italy Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Inhalation Anesthesia Market

  • 20.13. Spain Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Inhalation Anesthesia Market

  • 21.1. Eastern Europe Inhalation Anesthesia Market Overview
  • 21.2. Eastern Europe Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21. 4. Eastern Europe Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Inhalation Anesthesia Market

  • 22.1. Russia Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Inhalation Anesthesia Market

  • 23.1. North America Inhalation Anesthesia Market Overview
  • 23.2. North America Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23. 4. North America Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Inhalation Anesthesia Market

  • 24.1. USA Inhalation Anesthesia Market Overview
  • 24.2. USA Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24. 4. USA Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Inhalation Anesthesia Market

  • 25.1. Canada Inhalation Anesthesia Market Overview
  • 25.2. Canada Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25. 4. Canada Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Inhalation Anesthesia Market

  • 26.1. South America Inhalation Anesthesia Market Overview
  • 26.2. South America Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26. 4. South America Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Inhalation Anesthesia Market

  • 27.1. Brazil Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Inhalation Anesthesia Market

  • 28.1. Middle East Inhalation Anesthesia Market Overview
  • 28.2. Middle East Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28. 4. Middle East Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Inhalation Anesthesia Market

  • 29.1. Africa Inhalation Anesthesia Market Overview
  • 29.2. Africa Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29. 4. Africa Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Inhalation Anesthesia Market Competitive Landscape And Company Profiles

  • 30.1. Inhalation Anesthesia Market Competitive Landscape
  • 30.2. Inhalation Anesthesia Market Company Profiles
    • 30.2.1. Abbvie Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1. 4. Financial Performance
    • 30.2.2. Baxter International Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2. 4. Financial Performance
    • 30.2.3. Fresenius SE & Co. KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3. 4. Financial Performance
    • 30.2. 4. Halocarbon Products Corporation
      • 30.2. 4.1. Overview
      • 30.2. 4.2. Products and Services
      • 30.2. 4.3. Strategy
      • 30.2. 4. 4. Financial Performance
    • 30.2. 5. Hikma Pharmaceuticals PLC
      • 30.2. 5.1. Overview
      • 30.2. 5.2. Products and Services
      • 30.2. 5.3. Strategy
      • 30.2. 5. 4. Financial Performance

31. Global Inhalation Anesthesia Market Competitive Benchmarking

32. Global Inhalation Anesthesia Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Inhalation Anesthesia Market

34. Inhalation Anesthesia Market Future Outlook and Potential Analysis

  • 34.1 Inhalation Anesthesia Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Inhalation Anesthesia Market In 2028 - Segments Offering Most New Opportunities
  • 34. 3 Inhalation Anesthesia Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35. 4. Research Inquiries
  • 35. 5. The Business Research Company
  • 35. 6. Copyright And Disclaimer